T2 Biosystems, Inc. (TTOO)
OTCMKTS · Delayed Price · Currency is USD
0.0002
-0.0007 (-77.78%)
At close: Jul 23, 2026
T2 Biosystems Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue Revenue Growth | 7.68 | 7.19 | 22.31 | 28.06 | 18.13 | 8.34 |
Revenue Growth | -30.19% | -67.75% | -20.50% | 54.76% | 117.52% | -20.62% |
Gross Profit Gross Profit Growth | -19.03 | -22.32 | -24.42 | -14.45 | -18.63 | -24.75 |
Operating Income Operating Income Growth | -41.66 | -47.15 | -55.05 | -42.97 | -40.2 | -52.06 |
Net Income Net Income Growth | -42.95 | -50.08 | -62.33 | -49.24 | -46.8 | -59.01 |
Earnings Per Share EPS Growth | -4.08 | -19.19 | -1222.14 | -1549.82 | -1928.54 | - |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Italy Italy Growth | 0.9 | 1.3 | 1.3 | - | - | - |
Other International Other International Growth | 1.5 | 1.4 | 2.6 | - | - | - |
United States United States Growth | 4.58 | 4.49 | 18.41 | 25.76 | 16.13 | 5.54 |
Total Total Growth | 7.68 | 7.19 | 22.31 | 28.06 | 18.13 | 8.34 |
| Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Investments Cash & Investments Growth | 2.08 | 15.69 | 10.33 | 32.24 | 52.19 | 11.03 |
Total Debt Total Debt Growth | 18.94 | 49.5 | 59.22 | 58.32 | 57.93 | 49.18 |
Net Cash (Debt) Net Cash Growth | -16.86 | -33.81 | -48.89 | -26.08 | -5.74 | -38.15 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1.60 | -12.95 | -958.53 | -820.91 | -236.46 | - |
| Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Operating Cash Flow Operating Cash Flow Growth | -36.59 | -48.14 | -50.63 | -38.87 | -43.22 | -45.36 |
Capital Expenditures CapEx Growth | -0.03 | -0.19 | -0.34 | -0.46 | -0.8 | -0.76 |
Free Cash Flow Free Cash Flow Growth | -36.62 | -48.33 | -50.97 | -39.33 | -44.02 | -46.12 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Gross Margin | -247.83% | - | -109.48% | -51.49% | -102.74% | -296.99% |
Operating Margin | -542.60% | -655.54% | -246.78% | -153.16% | -221.72% | -624.57% |
Pretax Margin | -559.52% | -696.19% | -277.98% | -175.50% | -258.12% | -707.93% |
Profit Margin | -559.51% | -696.19% | -279.46% | -175.50% | -258.13% | -707.93% |
FCF Margin | -476.98% | -671.88% | -228.50% | -140.19% | -242.80% | -553.35% |
| Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 26, 2026 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
PS Ratio | 0.00 | 3.53 | 0.47 | 3.05 | 10.12 | 6.55 |